entertainment -WSS

entertainment

author：fashion 2025-10-02 21:05:32 - browse：23

An Ozempic pen connects dots that make up the shape o a brain — coverage from STAT — ILLUSTRATION: CHRISTINE KAO/STAT; PHOTOS: ADOBE

Drugs like Ozempic and Wegovy — already game changers for diabetes and obesity — are being studied to treat an entirely different growing health problem: mental health illnesses, including depression and bipolar disorder.

Early data and anecdotes suggest that this class of GLP-1 drugs could help patients feel less depressed and anxious. The treatment may also fight the decline in cognitive and executive function that many people with mental health disorders experience, like worsening memory and losing the ability to focus and plan.

If further research yields positive results, it could drive even more demand for the highly popular GLP-1 treatments, which have increasingly been shown to help with problems across the body, such as heart and kidney complications. And especially if the cognitive benefits are proven out, the GLP-1 drugs would plug a critical gap in current treatments for depression, since most depression drugs help with mood, but close to none address cognitive symptoms that affect memory and attention.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Chemotherapy shortages won’t get better under Biden’s latest plan

WSS

Spinal cord stimulation reduces pain in amputees, study finds

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

How climate

Chemotherapy shortages won’t get better under Biden’s latest plan

STAT Summit: Biotech founders on deal

STAT Summit: GSK CEO on pharma giant's new direction

focus

entertainment

knowledge

Jerome Adams on the need for new antivirals for Covid

STAT Summit: How a Chicago ER doctor tackles gun violence

Jerome Adams on the need for new antivirals for Covid

STAT Readout Newsletter: Today's biggest biotech updates

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

FDA gives detailed accounting of AI

Medical records are filled with copy

In diabetes hearing, Sanders takes on a new foe: food makers

In Memoriam: Notable people who died in 2023

STAT Readout Newsletter: Today's biggest biotech updates

leisure time

STAT Summit: Biotech founders on deal

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

In diabetes hearing, Sanders takes on a new foe: food makers

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

How climate

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Wikipedia

Wikipedia

leisure time

knowledge